Skip to main content

Table 6 Adjusted associations between fasting blood glucose and fructosamine in those with confirmed type 2 diabetes

From: The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study

 

MODEL 1

MODEL 2

β

95% CI

p

β

95% CI

p

Fructosamine

0.03

0.02 to 0.04

< 0.0001

0.03

0.02 to 0.04

< 0.0001

Age

− 0.08

−0.14 to − 0.03

0.003

−0.07

− 0.13 to − 0.02

0.008

Gender

− 0.08

−1.51 to 1.36

0.916

0.23

−1.19 to 1.65

0.750

CKD

−0.47

−5.61 to 4.67

0.857

−1.39

−6.47 to 3.69

0.589

CKDxFruc

0.00

−0.01 to 0.02

0.586

0.01

−0.01 to 0.02

0.369

BMI

0.08

0.01 to 0.16

0.035

Adjusted R2

0.56

0.57

  1. Data represents β-coefficients, 95% confidence interval, p-value and adjusted-R2. BMI, body mass index; CKD, chronic kidney disease; CKDxfruc, interaction between CKD and fructosamine. Model 1: fructosamine + age + gender + CKD + CKDxFruc; Model 2: Model 1 + BMI